CW March 2002
Volume 11Issue Number 3 March 2002 ISSN 10593802 New Treatment for Advanced Pancreatic CancerA combination of irinotecan and gemcitabine shows a promise in treating advance stage pancreatic cancer. The regimen is well tolerated and the treatment produced a one-year survival rate of 27%, which is greater than that reported with gemcitabine alone in previous studies.
Go to Previous Page Go to Next Page Source & Additional Reading C. M. S. Rocha Lima et al., Journal of Clinical Oncology, March 1, 2002. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW March 2002Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
